By Ryan Davis ( October 19, 2017, 9:15 PM EDT) -- The Federal Circuit on Thursday reversed a lower court's decision that some claims of a Merck patent on the birth control device NuvaRing are invalid, ruling in a dispute involving a Teva unit that the judge improperly used hindsight to find the patent obvious....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.